Deutsche Bank Fined $132M Over Bribery Schemes
U.S. authorities say the scandal-plagued bank made improper payments to politically-connected intermediaries to secure business overseas.
Goldman Sachs to Claw Back Exec Bonuses and Cut Compensation
Goldman Sachs also agreed to pay more than $2.9 billion as part of a deferred prosecution agreement with the U.S. Department of Justice.
Herbalife Fined $123M Over China Bribe Scheme
U.S. authorities say the company paid off Chinese governmental officials to win favorable treatment in one of its largest markets.
SEC Charges Consumer Loan Company With FCPA Violation
World Acceptance's former Mexico subsidiary paid more than $4 million in bribes to Mexican officials, said the SEC.
Alexion Fined $21M in Foreign Corruption Probe
The SEC says the biotech firm made improper payments to Turkish and Russian officials to secure favorable treatment for its main drug.
Novartis Settles U.S. Bribery Charges
The pharma giant will pay more than $346 million to settle charges that it bribed doctors to prescribe their drugs.
Cardinal Health Fined $8M for FCPA Violations
The SEC says Cardinal employees made improper payments to boost the sales of a skincare company whose products they were distributing in China.
Ericsson to Pay $1B in 2nd-Largest FCPA Case
“Through slush funds, bribes, gifts, and graft, Ericsson conducted telecom business with the guiding principle that ‘money talks.'"
IFF Discloses ‘Improper Payments’ by Israel Unit
The flavorings giant says its investigation indicates senior officials of Frutarom were aware of the payments to customers in Russia and Ukraine.
Fresenius Medical Fined $231M in Bribery Probe
The German medical device company allegedly paid $31 million in bribes to doctors and public health officials in at least 17 countries.
Insys Shares Dive on ‘Going Concern’ Doubts
The opioid seller's auditor expressed "substantial doubt" about its ability to continue as a going concern.